Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#61 / 200 Total
BRTX - BioRestorative Therapies Inc - Stock Price Chart
TickerBRTX [NASD]
CompanyBioRestorative Therapies Inc
CountryUSA
IndustryBiotechnology
Market Cap11.69MEPS (ttm)-1.22
P/E-EPS this Y51.07%
Forward P/E-EPS next Y-0.70%
PEG-EPS past 5Y79.34%
P/S68.79EPS next 5Y-
P/B1.08EPS Q/Q35.32%
Dividend-Sales Q/Q38.14%
Insider Own26.34%Inst Own13.18%
Insider Trans0.46%Inst Trans1.97%
Short Float1.01%EarningsAug 13/a
Analyst Recom1.00Target Price13.00
Avg Volume1.67M52W Range1.03 - 3.67
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Silva FranciscoVP of Research and DevelopmentApr 09 '24Buy1.256,6008,250155,759Apr 10 05:16 PM
Silva FranciscoVP of Research and DevelopmentApr 08 '24Buy1.161,7081,979149,159Apr 10 05:16 PM
Broadrick Dale10% OwnerFeb 09 '24Buy1.3286,041113,574477,972Feb 12 09:26 AM
Broadrick Dale10% OwnerFeb 08 '24Buy1.2573,95992,449391,931Feb 12 09:26 AM
Broadrick Dale10% OwnerFeb 08 '24Buy1.3483,626112,059447,045Feb 09 08:00 AM
PROP - Prairie Operating Co - Stock Price Chart
TickerPROP [NASD, RUT]
CompanyPrairie Operating Co
CountryUSA
IndustryCapital Markets
Market Cap129.62MEPS (ttm)-9.24
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y5.32%
P/S94.61EPS next 5Y-
P/B3.65EPS Q/Q86.83%
Dividend-Sales Q/Q-100.00%
Insider Own0.00%Inst Own5.09%
Insider Trans-Inst Trans-
Short Float1.62%EarningsAug 28
Analyst Recom1.00Target Price15.50
Avg Volume80.06K52W Range3.00 - 18.50
Prairie Operating Co. engages in development, exploration, and production of oil, natural gas, and natural gas liquids. It focuses on unconventional oil and natural gas reservoirs located in Colorado focused on the Niobrara and Codell formations. The company is also a crypto company involved in cryptocurrency mining. Prairie Operating was founded by Gary C. Hanna and Edward Kovalik on May 2, 2001 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thoresen ErikDirectorJun 21 '24Sale10.761992,1414,512Jun 25 08:28 PM
Thoresen ErikDirectorJun 24 '24Sale10.811151,2434,397Jun 25 08:28 PM
Thoresen ErikDirectorJun 25 '24Sale11.101111,2324,286Jun 25 08:28 PM
KESSLER PAUL L.DirectorJun 21 '24Sale10.761992,1417,762Jun 25 08:28 PM
KESSLER PAUL L.DirectorJun 24 '24Sale10.811151,2437,647Jun 25 08:28 PM
ZAPP - Zapp Electric Vehicles Group Ltd - Stock Price Chart
TickerZAPP [NASD]
CompanyZapp Electric Vehicles Group Ltd
CountryUnited Kingdom
IndustryAuto Manufacturers
Market Cap14.73MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-7.52%
Dividend-Sales Q/Q-
Insider Own37.45%Inst Own4.67%
Insider Trans0.00%Inst Trans-
Short Float5.06%EarningsJun 20/b
Analyst Recom1.00Target Price27.50
Avg Volume7.96M52W Range0.70 - 29.20
Zapp Electric Vehicles Group Ltd. engages in the provision of designs, manufactures and sells electric vehicles. It operates through the following geographical segments: Cayman Islands, Europe, and Thailand. It offers maintenance and repair of motorcycles and related parts and accessories. The company was founded by Swin Chatsuwan, Jeremy North, Warin Thanathawee and Kiattipong Arttachariya in 2017 and is headquartered in London, the United Kingdom.
EGRX - Eagle Pharmaceuticals Inc - Stock Price Chart
TickerEGRX [NASD]
CompanyEagle Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap55.99MEPS (ttm)0.91
P/E4.73EPS this Y-
Forward P/E-EPS next Y-
PEG1.75EPS past 5Y-3.56%
P/S0.22EPS next 5Y2.70%
P/B0.22EPS Q/Q153.33%
Dividend-Sales Q/Q-12.80%
Insider Own12.02%Inst Own76.83%
Insider Trans0.00%Inst Trans-
Short Float3.71%Earnings-
Analyst Recom3.00Target Price17.00
Avg Volume145.68K52W Range3.21 - 17.32
Aug-27-24 04:30PM Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq (GlobeNewswire) +9.24%
May-22-24 09:00AM Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq (GlobeNewswire) -12.81%
Apr-30-24 08:00AM Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at the Upcoming Society for Ambulatory Anesthesia (SAMBA) 2024 Annual Meeting (GlobeNewswire)
Apr-15-24 07:00AM Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida (GlobeNewswire) +13.29%
Apr-12-24 04:05PM Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K (GlobeNewswire)
Feb-05-24 09:55AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Feb-01-24 04:05PM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Jan-26-24 12:33PM EGRX STOCKHOLDERS: Robbins LLP Reminds Eagle Pharmaceuticals Shareholders of Pending Lead Plaintiff Deadline February 9, 2024 (GlobeNewswire)
Jan-24-24 09:45AM EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-18-24 06:50AM Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio (GlobeNewswire)
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tarriff ScottCEONov 01 '23Sale13.8210,925150,984556,141Nov 03 04:39 PM
Tarriff ScottCEONov 02 '23Sale13.8710,694148,326545,447Nov 03 04:39 PM
Graves MichaelDirectorOct 27 '23Option Exercise4.949,36046,23810,360Oct 31 05:41 PM
Tarriff ScottCEOOct 03 '23Sale14.4610,734155,174567,066Oct 04 05:07 PM
Tarriff ScottCEOOct 02 '23Sale15.239,511144,853577,800Oct 04 05:07 PM
CNTA - Centessa Pharmaceuticals plc ADR - Stock Price Chart
TickerCNTA [NASD]
CompanyCentessa Pharmaceuticals plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap1.92BEPS (ttm)-1.56
P/E-EPS this Y0.09%
Forward P/E-EPS next Y-6.74%
PEG-EPS past 5Y-
P/S278.28EPS next 5Y-
P/B6.70EPS Q/Q-52.67%
Dividend-Sales Q/Q-
Insider Own33.28%Inst Own43.30%
Insider Trans-0.96%Inst Trans0.05%
Short Float2.61%EarningsAug 13/b
Analyst Recom1.29Target Price20.00
Avg Volume458.81K52W Range5.15 - 17.25
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weinhoff Gregory MChief Business OfficerSep 10 '24Option Exercise5.8430,000175,200253,369Sep 12 08:01 PM
Weinhoff Gregory MChief Business OfficerSep 10 '24Sale17.0030,000510,000223,369Sep 12 08:01 PM
SAHA SAURABHChief Executive OfficerSep 10 '24Option Exercise5.84175,0001,022,000951,924Sep 12 08:01 PM
SAHA SAURABHChief Executive OfficerSep 10 '24Sale16.52175,0002,891,822776,924Sep 12 08:01 PM
SAHA SAURABHOfficerSep 10 '24Proposed Sale16.52175,0002,891,822Sep 10 04:06 PM
SVV - Savers Value Village Inc - Stock Price Chart
TickerSVV [NYSE, RUT]
CompanySavers Value Village Inc
CountryUSA
IndustrySpecialty Retail
Market Cap1.63BEPS (ttm)0.22
P/E45.38EPS this Y-15.25%
Forward P/E16.97EPS next Y15.38%
PEG-EPS past 5Y-31.02%
P/S1.07EPS next 5Y-
P/B3.90EPS Q/Q-75.90%
Dividend-Sales Q/Q1.99%
Insider Own83.85%Inst Own24.84%
Insider Trans-0.12%Inst Trans-
Short Float27.03%EarningsAug 08/a
Analyst Recom1.62Target Price14.12
Avg Volume823.94K52W Range7.78 - 22.09
Savers Value Village, Inc. sells second-hand merchandise in retail stores. Its retail stores are located in the U.S., Canada, and Australia. The company was founded on March 22, 2019 and is headquartered in Bellevue, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Woods Duane C.DirectorJun 14 '24Option Exercise1.6845,81576,77453,037Jun 18 04:39 PM
Walsh Mark T.Chief Executive OfficerApr 08 '24Option Exercise1.4117,00023,97017,000Apr 10 04:39 PM
Walsh Mark T.Chief Executive OfficerApr 08 '24Sale18.6117,000316,3430Apr 10 04:39 PM
Medway Richard A.General CounselApr 03 '24Option Exercise1.412,8504,0182,850Apr 05 05:33 PM
Medway Richard A.General CounselApr 03 '24Sale19.132,85054,5200Apr 05 05:33 PM
DATS - DatChat Inc - Stock Price Chart
TickerDATS [NASD]
CompanyDatChat Inc
CountryUSA
IndustrySoftware - Application
Market Cap3.82MEPS (ttm)-2.53
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-15.32%
P/S-EPS next 5Y-
P/B0.62EPS Q/Q70.38%
Dividend-Sales Q/Q-12.21%
Insider Own9.19%Inst Own1.85%
Insider Trans0.00%Inst Trans-
Short Float0.87%Earnings-
Analyst Recom-Target Price-
Avg Volume997.39K52W Range1.01 - 5.03
DatChat, Inc. operates as a communication software company. Its product, DatChat Messenger & Private Social Network is a mobile application that gives users the ability to communicate with privacy and protection. The company's DatChat application allows users to exercise control over their messages, even after they are sent. Through the application, users can delete messages that they have sent, on their own device and the recipient's device as well. Its DatChat application also enables users to hide secret and encrypted messages behind a cover, which messages can only be unlocked by the recipient and which are automatically destroyed after a fixed number of views or fixed amount of time and also includes a screen shot protection system, which makes it virtually impossible for the recipient to screenshot a message or picture before it gets destroyed. Its application also integrates with iMessage, making private messages potentially available to hundreds of millions of users. The company was founded by Darin M. Myman and Peter Shelus on December 4, 2014 and is headquartered in New Brunswick, NJ.
PULM - Pulmatrix Inc - Stock Price Chart
TickerPULM [NASD]
CompanyPulmatrix Inc
CountryUSA
IndustryBiotechnology
Market Cap7.34MEPS (ttm)-2.97
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y47.79%
P/S0.64EPS next 5Y-
P/B0.55EPS Q/Q-52.29%
Dividend-Sales Q/Q-15.84%
Insider Own0.00%Inst Own6.90%
Insider Trans-Inst Trans-54.37%
Short Float0.14%EarningsAug 13/b
Analyst Recom1.00Target Price10.00
Avg Volume11.51K52W Range1.55 - 2.75
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.
SSP - E.W. Scripps Co. - Stock Price Chart
TickerSSP [NASD, RUT]
CompanyE.W. Scripps Co.
CountryUSA
IndustryBroadcasting
Market Cap173.10MEPS (ttm)-3.67
P/E-EPS this Y447.35%
Forward P/E-EPS next Y-148.79%
PEG-EPS past 5Y-
P/S0.07EPS next 5Y10.00%
P/B0.23EPS Q/Q98.12%
Dividend-Sales Q/Q-1.58%
Insider Own16.93%Inst Own68.60%
Insider Trans0.02%Inst Trans1.62%
Short Float6.16%EarningsAug 08/a
Analyst Recom3.00Target Price4.93
Avg Volume770.14K52W Range1.68 - 9.35
The E.W. Scripps Co. engages in television and newspaper publishing. It operates through the following business segments: Local Media, Scripps Networks, and Other. The Local Media segment consists of local broadcast television stations and their related digital operations. The Scripps Networks segment consists of national television networks. The company was founded in 1878 and is headquartered in Cincinnati, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scagliotti R. Michael10% OwnerMar 13 '24Buy4.162,3009,56841,747Mar 15 04:05 PM
Scripps John Patrick10% OwnerFeb 28 '24Buy4.502,1009,4603,236Mar 01 05:57 PM
Barmonde Charles L.DirectorFeb 29 '24Buy4.2810,50044,970642,401Mar 01 04:09 PM
Scripps John Patrick10% OwnerNov 14 '23Buy7.306704,8911,136Nov 15 09:03 PM
SMR - NuScale Power Corporation - Stock Price Chart
TickerSMR [NYSE, RUT]
CompanyNuScale Power Corporation
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap916.89MEPS (ttm)-1.02
P/E-EPS this Y-5.13%
Forward P/E-EPS next Y29.43%
PEG-EPS past 5Y-
P/S66.15EPS next 5Y-
P/B6.57EPS Q/Q-133.64%
Dividend-Sales Q/Q-83.31%
Insider Own15.71%Inst Own41.28%
Insider Trans-1.73%Inst Trans4.15%
Short Float24.73%EarningsAug 08/a
Analyst Recom1.60Target Price11.12
Avg Volume5.39M52W Range1.81 - 16.91
Sep-13-24Initiated CLSA Outperform $11
NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by Jose N. Reyes in 2007 and is headquartered in Portland, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Temple Robert KFormer OfficerSep 13 '24Proposed Sale9.575,00047,875Sep 13 03:26 PM
Hamady Robert RamseyChief Financial OfficerAug 26 '24Option Exercise0.0076,923076,923Aug 28 11:31 AM
Hamady Robert RamseyChief Financial OfficerAug 27 '24Sale7.9819,242153,60957,681Aug 28 11:31 AM
Hamady Robert RamseyOfficerAug 27 '24Proposed Sale7.9819,242153,613Aug 27 03:17 PM
Temple Robert KRetiredAug 13 '24Option Exercise3.4150,000170,50069,054Aug 15 12:24 PM
12345678910111220